Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-7-2
|
pubmed:abstractText |
Conventional spin-echo magnetic resonance imaging (MRI) of intraorbital optic neuritis is hampered by the adjacent high signal and chemical shift artifact of orbital fat. Frequency-selective saturation pulse MRI reduces these problems and was used to determine its utility in evaluation of intraorbital optic neuritis. Eight consecutive patients with optic neuritis underwent MRI within 1 week of the onset of visual loss. Conventional MRI with T1, proton density, and T2 weighting and frequency-selective saturation pulse MRI with T1, proton density, and T2 weighting were performed. After administration of intravenous gadopentetate dimeglumine, T1-weighted conventional and frequency-selective saturation pulse MRI were performed. Frequency-selective saturation pulse MRI showed gadopentetate dimeglumine enhancement in the intraorbital optic nerve in 7 patients and the intracranial optic nerve in 3 patients. Conventional MRI failed to show optic nerve gadopentetate dimeglumine enhancement in patients with intraorbital lesions, but did show intracranial lesions. Frequency-selective saturation pulse MRI showed bilateral optic nerve enhancement in 3 patients with unilateral visual signs and symptoms. Proton density and T2-weighted conventional MRI of the brain showed no convincing signal aberrations in the optic nerves. In the MRI evaluation of intraorbital optic neuritis: (1) frequency-selective saturation pulse fat suppression MRI is superior to T1-weighted conventional MRI in the detection of gadopentetate dimeglumine enhancement; (2) frequency-selective saturation pulse proton density and T2-weighted MRI is superior to proton density and T2-weighted conventional MRI; (3) frequency-selective saturation pulse MRI showed gadopentetate dimeglumine enhancement as well as proton density/T2-weighted signal aberration in exactly the same portion of the intraorbital optic nerve.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Contrast Media,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Gadolinium,
http://linkedlifedata.com/resource/pubmed/chemical/Gadolinium DTPA,
http://linkedlifedata.com/resource/pubmed/chemical/Meglumine,
http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Pentetic Acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0161-6420
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
713-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1594216-Adult,
pubmed-meshheading:1594216-Contrast Media,
pubmed-meshheading:1594216-Demyelinating Diseases,
pubmed-meshheading:1594216-Drug Combinations,
pubmed-meshheading:1594216-Female,
pubmed-meshheading:1594216-Gadolinium,
pubmed-meshheading:1594216-Gadolinium DTPA,
pubmed-meshheading:1594216-Humans,
pubmed-meshheading:1594216-Magnetic Resonance Imaging,
pubmed-meshheading:1594216-Meglumine,
pubmed-meshheading:1594216-Optic Nerve Diseases,
pubmed-meshheading:1594216-Optic Neuritis,
pubmed-meshheading:1594216-Orbit,
pubmed-meshheading:1594216-Organometallic Compounds,
pubmed-meshheading:1594216-Pentetic Acid,
pubmed-meshheading:1594216-Visual Acuity
|
pubmed:year |
1992
|
pubmed:articleTitle |
Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging.
|
pubmed:affiliation |
Department of Ophthalmology, University of Florida, Gainesville 32610-0284.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|